S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
⚡ 2,467% Return on Israeli Laser Company? (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
The single greatest medical breakthrough of all time? (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
The single greatest medical breakthrough of all time? (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
⚡ 2,467% Return on Israeli Laser Company? (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
The single greatest medical breakthrough of all time? (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
The single greatest medical breakthrough of all time? (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
⚡ 2,467% Return on Israeli Laser Company? (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
The single greatest medical breakthrough of all time? (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
The single greatest medical breakthrough of all time? (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
⚡ 2,467% Return on Israeli Laser Company? (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
The single greatest medical breakthrough of all time? (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
The single greatest medical breakthrough of all time? (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
NASDAQ:AZTA

Azenta (AZTA) Stock Forecast, Price & News

$44.72
+1.65 (+3.83%)
(As of 06/6/2023 ET)
Compare
Today's Range
$43.06
$45.14
50-Day Range
$36.45
$46.12
52-Week Range
$36.01
$78.82
Volume
630,862 shs
Average Volume
1.12 million shs
Market Capitalization
$2.91 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$64.20

Azenta MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
43.6% Upside
$64.20 Price Target
Short Interest
Healthy
9.36% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.07mentions of Azenta in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
300.00%
From $0.15 to $0.60 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.57 out of 5 stars

Medical Sector

152nd out of 981 stocks

Medical Instruments & Supplies Industry

1st out of 1 stocks


AZTA stock logo

About Azenta (NASDAQ:AZTA) Stock

Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

Receive AZTA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Azenta and its competitors with MarketBeat's FREE daily newsletter.

AZTA Stock News Headlines

Vazyme Signs Global Strategic Cooperation Agreement with Azenta
This NASDAQ Stock Is The Amazon Of Medical Supply
This Little Known Company IS Quickly Becoming The Amazon Of Medical Supply. Learn More Now
Azenta (AZTA) Declined on Weak Management Guidance
[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
Azenta (NASDAQ:AZTA) Hits New 1-Year Low After Earnings Miss
Analyst Ratings for Azenta
Azenta (NASDAQ:AZTA) Issues Q3 Earnings Guidance
Azenta's Earnings Outlook
Azenta (AZTA) to Release Quarterly Earnings on Tuesday
Here’s Why Polen Capital Sold Azenta (AZTA)
Short Interest in Azenta, Inc. (NASDAQ:AZTA) Rises By 53.8%
See More Headlines

AZTA Price History

AZTA Company Calendar

Last Earnings
5/09/2023
Today
6/06/2023
Next Earnings (Estimated)
8/08/2023
Fiscal Year End
9/30/2023

Industry, Sector and Symbol

Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AZTA
Employees
3,600
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$64.20
High Stock Price Forecast
$70.00
Low Stock Price Forecast
$55.00
Forecasted Upside/Downside
+43.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Net Income
$2.13 billion
Pretax Margin
-4.06%

Debt

Sales & Book Value

Annual Sales
$555.50 million
Cash Flow
$1.21 per share
Book Value
$44.83 per share

Miscellaneous

Free Float
64,079,000
Market Cap
$2.91 billion
Optionable
Optionable
Beta
1.56

Key Executives

  • Dr. Stephen S. Schwartz (Age 64)
    CEO, Pres & Director
    Comp: $1.17M
  • Mr. Lindon G. Robertson (Age 61)
    Exec. VP & CFO
    Comp: $1M
  • Ms. Vandana Sriram (Age 49)
    Sr. VP of Global Fin., Corp. Controller & Principal Accounting Officer
    Comp: $800.2k
  • Mr. Jason W. Joseph (Age 52)
    Sr. VP, Gen. Counsel & Corp. Sec.
    Comp: $651.75k
  • Mr. Michael Paulo
    VP and Chief Information & Digital Officer
  • Sara Silverman
    Head of Investor Relations & Corp. Communications
  • Mr. John E. O'Brien (Age 53)
    Sr. VP of Corp. Devel.
  • Dr. Claribel Purcell
    Sr. VP of Global Sales
  • Mr. J. Robert Woodward
    Sr. VP of Global Quality & Regulatory
  • Mr. David C. Gray Ph.D. (Age 57)
    Sr. VP and Chief Strategy & New Bus. Officer













AZTA Stock - Frequently Asked Questions

Should I buy or sell Azenta stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Azenta in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" AZTA shares.
View AZTA analyst ratings
or view top-rated stocks.

What is Azenta's stock price forecast for 2023?

4 analysts have issued twelve-month price targets for Azenta's stock. Their AZTA share price forecasts range from $55.00 to $70.00. On average, they expect the company's stock price to reach $64.20 in the next year. This suggests a possible upside of 43.6% from the stock's current price.
View analysts price targets for AZTA
or view top-rated stocks among Wall Street analysts.

How have AZTA shares performed in 2023?

Azenta's stock was trading at $58.22 at the beginning of the year. Since then, AZTA stock has decreased by 23.2% and is now trading at $44.72.
View the best growth stocks for 2023 here
.

Are investors shorting Azenta?

Azenta saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 5,980,000 shares, a decrease of 15.4% from the April 30th total of 7,070,000 shares. Based on an average daily volume of 1,200,000 shares, the short-interest ratio is currently 5.0 days. Approximately 9.4% of the company's shares are short sold.
View Azenta's Short Interest
.

When is Azenta's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023.
View our AZTA earnings forecast
.

How were Azenta's earnings last quarter?

Azenta, Inc. (NASDAQ:AZTA) posted its earnings results on Tuesday, May, 9th. The company reported ($0.06) earnings per share for the quarter, missing analysts' consensus estimates of ($0.04) by $0.02. The business had revenue of $148.40 million for the quarter, compared to analysts' expectations of $161.90 million. Azenta had a positive trailing twelve-month return on equity of 0.81% and a negative net margin of 7.79%. Azenta's revenue was up 2.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.12 EPS.

What guidance has Azenta issued on next quarter's earnings?

Azenta updated its third quarter earnings guidance on Tuesday, May, 9th. The company provided earnings per share (EPS) guidance of ($0.07)-$0.03 for the period, compared to the consensus EPS estimate of $0.06. The company issued revenue guidance of $150-$168 million, compared to the consensus revenue estimate of $170.72 million.

What is Azenta's stock symbol?

Azenta trades on the NASDAQ under the ticker symbol "AZTA."

Who are Azenta's major shareholders?

Azenta's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (9.81%), Kayne Anderson Rudnick Investment Management LLC (6.46%), JPMorgan Chase & Co. (4.63%), Allspring Global Investments Holdings LLC (3.43%), State Street Corp (3.03%) and Brown Advisory Inc. (2.60%). Insiders that own company stock include Jesus Linda De, Kimberly Crowley, Lindon G Robertson and Matthew Mcmanus.
View institutional ownership trends
.

How do I buy shares of Azenta?

Shares of AZTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Azenta's stock price today?

One share of AZTA stock can currently be purchased for approximately $44.72.

How much money does Azenta make?

Azenta (NASDAQ:AZTA) has a market capitalization of $2.91 billion and generates $555.50 million in revenue each year. The company earns $2.13 billion in net income (profit) each year or ($0.63) on an earnings per share basis.

How many employees does Azenta have?

The company employs 3,600 workers across the globe.

How can I contact Azenta?

Azenta's mailing address is 15 Elizabeth Dr, Chelmsford, Massachusetts 01824-4111. The official website for the company is www.brooks.com. The company can be reached via phone at (978) 262-2400, via email at investor@brooks.com, or via fax at 978-262-2500.

This page (NASDAQ:AZTA) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -